Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001437749-21-006841
Filing Date
2021-03-23
Accepted
2021-03-23 07:01:23
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 atos20210320_424b5.htm 424B5 371519
2 atos20210320_424b5img001.jpg GRAPHIC 5160
3 atos20210320_424b5img002.jpg GRAPHIC 5233
  Complete submission text file 0001437749-21-006841.txt   387160
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Filer) CIK: 0001488039 (see all company filings)

EIN.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-248555 | Film No.: 21763129
SIC: 2834 Pharmaceutical Preparations